The recognition that a subset of oropharynx cancers arise because of transforming human papillomavirus (HPV) infection was followed by evidence that not only did these cancers have a different epidemiology from the historically more prevalent tobacco-associated head and neck cancers, but they also had strikingly different biology, natural history, treatment responsiveness, and prognosis.